glp 1 truth serum podcast GLP-1 Pod S2E2: "Marketing Isn't Medicine" - GLP-1 Truth Serum GLP-1 Truth Serum Pod: Season

However, real-world adherence to these medications beyond the short term remains a concern, with previous studies indicating adherence rates between 20% and 50% after 12 months 1-4

Hunger is not just a nuisance

Less than a month after that Super Bowl ad aired, the FDA began announcing new policies that require compounding pharmacies to stop making compounded semaglutide and tirzepatide (the active ingredients in Ozempic and Mounjaro, respectively), which also meansin theorythat telemedicine companies need to stop selling these drugs

Study: Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk